- Home
- NBIX vs CIB Comparison
NBIX vs CIB Comparison
Compare NBIX & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- CIB
- Stock Information
- Founded
- NBIX 1992
- CIB 1945
- Country
- NBIX United States
- CIB Colombia
- Employees
- NBIX N/A
- CIB N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- CIB Commercial Banks
- Sector
- NBIX Health Care
- CIB Finance
- Exchange
- NBIX Nasdaq
- CIB Nasdaq
- Market Cap
- NBIX 13.2B
- CIB 10.6B
- IPO Year
- NBIX 1996
- CIB 1995
- Fundamental
- Price
- NBIX $128.91
- CIB $44.12
- Analyst Decision
- NBIX Strong Buy
- CIB Sell
- Analyst Count
- NBIX 22
- CIB 5
- Target Price
- NBIX $165.59
- CIB $39.00
- AVG Volume (30 Days)
- NBIX 935.9K
- CIB 218.2K
- Earning Date
- NBIX 07-30-2025
- CIB 08-15-2025
- Dividend Yield
- NBIX N/A
- CIB 14.84%
- EPS Growth
- NBIX 2.97
- CIB 4.59
- EPS
- NBIX 3.39
- CIB 1.57
- Revenue
- NBIX $2,509,900,000.00
- CIB $5,380,508,149.00
- Revenue This Year
- NBIX $16.12
- CIB $29.45
- Revenue Next Year
- NBIX $15.06
- CIB $5.88
- P/E Ratio
- NBIX $38.04
- CIB $7.70
- Revenue Growth
- NBIX 18.42
- CIB 6.91
- 52 Week Low
- NBIX $84.23
- CIB $30.25
- 52 Week High
- NBIX $157.98
- CIB $46.81
- Technical
- Relative Strength Index (RSI)
- NBIX 46.34
- CIB 48.54
- Support Level
- NBIX $130.75
- CIB $43.28
- Resistance Level
- NBIX $137.44
- CIB $44.86
- Average True Range (ATR)
- NBIX 3.60
- CIB 1.05
- MACD
- NBIX -0.71
- CIB -0.23
- Stochastic Oscillator
- NBIX 33.88
- CIB 25.15
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CIB BanColombia S.A.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.